Variability in Sertraline Pharmacokinetics in Routine Clinical Practice: Influence of Sex, Age, Body Weight, Smoking, and Co‐Medication
Fundamental & Clinical Pharmacology · 2026
DOI: 10.1111/fcp.70114 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Fundamental & Clinical Pharmacology, 2026. Verfasst von Begoña Tapia-Alzuguren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Service, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Antidepressive Agents, Selective Serotonin Reuptake Inhibitors, Sertraline, Smoking. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To investigate the influence of sex, age, body weight, smoking habits, and co‐medications on sertraline pharmacokinetics in a routine clinical setting.
Methods
This retrospective observational study analyzed 177 predominantly inpatient therapeutic drug monitoring records from 101 patients receiving sertraline as monotherapy or polytherapy. Pharmacokinetic parameters—serum concentrations (CSER), concentration‐to‐dose ratio (CDR), weight‐normalized CDR (CDR/kg), apparent clearance (CL/F), and metabolite‐to‐parent ratio (N‐SER/SER)—were compared across subgroups defined by sex, age (< 18; 18–65; > 65 years), BMI, smoking, and co‐medications. To address the nonindependence of repeated measurements, analyses were complemented using linear mixed‐effects models and a sensitivity analysis restricted to one observation per patient.
Results
Descriptive analyses suggested higher CDR/kg in males and higher CSER in elderly patients. After accounting for within‐patient clustering, the increase in CDR/kg across BMI categories remained the most consistent finding, likely reflecting mathematical normalization. The higher CSER observed in elderly patients persisted in the mixed‐effects model but not in the sensitivity analysis, although the direction of effect remained consistent. Sex‐related differences were not robust after adjustment and were largely attributable to body weight. Smoking showed no measurable effect. Among co‐medications, carbamazepine showed the most consistent pharmacokinetic signal, whereas other findings were less consistent.
Conclusion
Elderly age may contribute to higher sertraline concentrations; however, its effect appears modest after accounting for clustering. Sex differences are largely explained by body weight, and smoking does not appear to influence pharmacokinetics. Carbamazepine showed a consistent induction pattern, whereas other co‐medication findings should be considered exploratory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Service, Clínica Universidad de Navarra, Pamplona, Spain.
- Department of Psychiatry and Clinical Psychology, Clínica Universidad de Navarra, Pamplona, Spain.
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
ORCID-Profile: Begoña Tapia-Alzuguren, Covadonga Canga-Espina, Patricio Molero
Zitieren
APA
Tapia-Alzuguren, B., Canga-Espina, C., Molero, P., & Aldaz, A. (2026). Variability in Sertraline Pharmacokinetics in Routine Clinical Practice: Influence of Sex, Age, Body Weight, Smoking, and Co‐Medication. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.70114
Vancouver
Tapia-Alzuguren B, Canga-Espina C, Molero P, Aldaz A. Variability in Sertraline Pharmacokinetics in Routine Clinical Practice: Influence of Sex, Age, Body Weight, Smoking, and Co‐Medication. Fundamental & Clinical Pharmacology. 2026. doi:10.1111/fcp.70114
BibTeX
@article{TapiaAlzuguren2026,
author = {Tapia-Alzuguren, Begoña and Canga-Espina, Covadonga and Molero, Patricio and Aldaz, Azucena},
title = {Variability in Sertraline Pharmacokinetics in Routine Clinical Practice: Influence of Sex, Age, Body Weight, Smoking, and Co‐Medication},
journal = {Fundamental & Clinical Pharmacology},
year = {2026},
doi = {10.1111/fcp.70114}
}
EUVIMED